163 related articles for article (PubMed ID: 37928442)
1. Efficacy and safety of a SOD1-targeting artificial miRNA delivered by AAV9 in mice are impacted by miRNA scaffold selection.
Chen SK; Hawley ZCE; Zavodszky MI; Hana S; Ferretti D; Grubor B; Hawes M; Xu S; Hamann S; Marsh G; Cullen P; Challa R; Carlile TM; Zhang H; Lee WH; Peralta A; Clarner P; Wei C; Koszka K; Gao F; Lo SC
Mol Ther Nucleic Acids; 2023 Dec; 34():102057. PubMed ID: 37928442
[TBL] [Abstract][Full Text] [Related]
2. Slow Intrathecal Injection of rAAVrh10 Enhances its Transduction of Spinal Cord and Therapeutic Efficacy in a Mutant SOD1 Model of ALS.
Li D; Liu C; Yang C; Wang D; Wu D; Qi Y; Su Q; Gao G; Xu Z; Guo Y
Neuroscience; 2017 Dec; 365():192-205. PubMed ID: 29024785
[TBL] [Abstract][Full Text] [Related]
3. Silencing strategies for therapy of SOD1-mediated ALS.
van Zundert B; Brown RH
Neurosci Lett; 2017 Jan; 636():32-39. PubMed ID: 27507699
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic rAAVrh10 Mediated SOD1 Silencing in Adult SOD1(G93A) Mice and Nonhuman Primates.
Borel F; Gernoux G; Cardozo B; Metterville JP; Toro Cabrera GC; Song L; Su Q; Gao GP; Elmallah MK; Brown RH; Mueller C
Hum Gene Ther; 2016 Jan; 27(1):19-31. PubMed ID: 26710998
[TBL] [Abstract][Full Text] [Related]
5. Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques.
Borel F; Gernoux G; Sun H; Stock R; Blackwood M; Brown RH; Mueller C
Sci Transl Med; 2018 Oct; 10(465):. PubMed ID: 30381409
[TBL] [Abstract][Full Text] [Related]
6. Efficient and Precise Processing of the Optimized Primary Artificial MicroRNA in a Huntingtin-Lowering Adeno-Associated Viral Gene Therapy
Wang W; Zhou P; Wang X; Chen F; Christensen E; Thompson J; Ren X; Kells A; Stanek L; Carter T; Hou J; Sah DWY
Hum Gene Ther; 2022 Jan; 33(1-2):37-60. PubMed ID: 34806402
[TBL] [Abstract][Full Text] [Related]
7. In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model.
Chen YA; Kankel MW; Hana S; Lau SK; Zavodszky MI; McKissick O; Mastrangelo N; Dion J; Wang B; Ferretti D; Koske D; Lehman S; Koszka K; McLaughlin H; Liu M; Marshall E; Fabian AJ; Cullen P; Marsh G; Hamann S; Craft M; Sebalusky J; Arnold HM; Driscoll R; Sheehy A; Luo Y; Manca S; Carlile T; Sun C; Sigrist K; McCampbell A; Henderson CE; Lo SC
Gene Ther; 2023 May; 30(5):443-454. PubMed ID: 36450833
[TBL] [Abstract][Full Text] [Related]
8. Adeno Associated Viral Vector Delivered RNAi for Gene Therapy of SOD1 Amyotrophic Lateral Sclerosis.
Stoica L; Sena-Esteves M
Front Mol Neurosci; 2016; 9():56. PubMed ID: 27531973
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of intrathecal injection of AAV9-RabGGTB-GFP
Gao T; Huo J; Xin C; Yang J; Liu Q; Dong H; Li R; Liu Y
Front Aging Neurosci; 2023; 15():1092607. PubMed ID: 36967828
[TBL] [Abstract][Full Text] [Related]
10. Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice.
Towne C; Raoul C; Schneider BL; Aebischer P
Mol Ther; 2008 Jun; 16(6):1018-25. PubMed ID: 18414477
[TBL] [Abstract][Full Text] [Related]
11. Astrocyte-targeting RNA interference against mutated superoxide dismutase 1 induces motoneuron plasticity and protects fast-fatigable motor units in a mouse model of amyotrophic lateral sclerosis.
Rochat C; Bernard-Marissal N; Källstig E; Pradervand S; Perrin FE; Aebischer P; Raoul C; Schneider BL
Glia; 2022 May; 70(5):842-857. PubMed ID: 34978340
[TBL] [Abstract][Full Text] [Related]
12. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
13. Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS).
Abati E; Bresolin N; Comi G; Corti S
Expert Opin Ther Targets; 2020 Apr; 24(4):295-310. PubMed ID: 32125907
[No Abstract] [Full Text] [Related]
14. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
15. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
16. Altered miRNA expression is associated with neuronal fate in G93A-SOD1 ependymal stem progenitor cells.
Marcuzzo S; Kapetis D; Mantegazza R; Baggi F; Bonanno S; Barzago C; Cavalcante P; Kerlero de Rosbo N; Bernasconi P
Exp Neurol; 2014 Mar; 253():91-101. PubMed ID: 24365539
[TBL] [Abstract][Full Text] [Related]
17. Fenretinide Beneficial Effects on Amyotrophic Lateral Sclerosis-associated SOD1
Orienti I; Armida M; Dobrowolny G; Pepponi R; Sollazzini G; Pezzola A; Casola I; Musarò A; Popoli P; Potenza RL
Neuroscience; 2021 Oct; 473():1-12. PubMed ID: 34363869
[TBL] [Abstract][Full Text] [Related]
18. Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis.
Wang H; Yang B; Qiu L; Yang C; Kramer J; Su Q; Guo Y; Brown RH; Gao G; Xu Z
Hum Mol Genet; 2014 Feb; 23(3):668-81. PubMed ID: 24108104
[TBL] [Abstract][Full Text] [Related]
19. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1
Kreilaus F; Guerra S; Masanetz R; Menne V; Yerbury J; Karl T
Genes Brain Behav; 2020 Feb; 19(2):e12604. PubMed ID: 31412164
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of neural and cell cycle-related microRNAs in brain of amyotrophic lateral sclerosis mice at late disease stage.
Marcuzzo S; Bonanno S; Kapetis D; Barzago C; Cavalcante P; D'Alessandro S; Mantegazza R; Bernasconi P
Mol Brain; 2015 Jan; 8():5. PubMed ID: 25626686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
